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Abstract
Background: A population-based case-control study was undertaken in 1997 to investigate the
association between tetrachloroethylene (PCE) exposure from public drinking water and breast
cancer among permanent residents of the Cape Cod region of Massachusetts. PCE, a volatile
organic chemical, leached from the vinyl lining of certain water distribution pipes into drinking
water from the late 1960s through the early 1980s. The measure of exposure in the original study,
referred to as the relative delivered dose (RDD), was based on an amount of PCE in the tap water
entering the home and estimated with a mathematical model that involved only characteristics of
the distribution system.
Methods: In the current analysis, we constructed a personal delivered dose (PDD) model that
included personal information on tap water consumption and bathing habits so that inhalation,
ingestion, and dermal absorption were also considered. We reanalyzed the association between
PCE and breast cancer and compared the results to the original RDD analysis of subjects with
complete data.
Results:  The PDD model produced higher adjusted odds ratios than the RDD model for
exposures > 50th and >75th percentile when shorter latency periods were considered, and for
exposures < 50th and >90th percentile when longer latency periods were considered. Overall,
however, the results from the PDD analysis did not differ greatly from the RDD analysis.
Conclusion:  The inputs that most heavily influenced the PDD model were initial water
concentration and duration of exposure. These variables were also included in the RDD model. In
this study population, personal factors like bath and shower temperature, bathing frequencies and
durations, and water consumption did not differ greatly among subjects, so including this
information in the model did not significantly change subjects' exposure classification.
Background
In 1988, an unusually high incidence of cancer in the
Cape Cod region of Massachusetts prompted a series of
epidemiological studies to investigate possible environ-
mental risk factors associated with the region, including
tetrachloroethylene-contaminated drinking water [1-7].
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Tetrachloroethylene (or perchloroethylene, PCE) entered
the drinking water when it leached from vinyl liners of
water distribution pipes introduced in the late 1960s.
When the contamination was discovered, the Massachu-
setts Department of Environmental Protection began
flushing and bleeding the pipes in 1980. At that time, the
suggested limit set by the Environmental Protection
Agency (EPA) was 40 ppb [8], but has since been lowered
to a mandatory Maximum Contaminant Level (MCL) of 5
ppb.
A population-based case-control study was undertaken to
investigate the association between tetrachloroethylene
exposure from public drinking water and breast cancer
[5]. The study defined exposure using a cumulative meas-
ure Webler and Brown termed the relative delivered dose
(RDD) [9]. Calculations for the RDD use the rate at which
PCE leached from the pipe liner, the surface area of the
interior of the pipe, and the upstream load. The RDD is
relative to the total delivered mass of PCE entering each
residence over time, but the constants and variables
assumed to be constant were dropped from the analysis.
While this allowed for grouping of the population into
exposure categories, the RDD value computed is not an
actual water concentration. Refer to Webler and Brown for
a detailed description of the RDD model [9].
Because PCE is a volatile organic chemical that readily
escapes from water into air, the amount of PCE inhaled
during showers and baths, as well as the amount ingested
and dermally absorbed, was relevant. The RDD measure
does not consider these exposure pathways, which could
potentially result in bias from exposure misclassification.
Using personal exposure factors such as tap water con-
sumption and bathing habits, we constructed a dose
model to quantify the relative amount of PCE taken in by
each subject, which we refer to as the personal delivered
dose (PDD). The dose values calculated by the PDD
model were subsequently used to measure the strength of
the association between PCE exposure and the risk of
breast cancer. The objective was to see if additional infor-
mation contained in individual survey data affected asso-
ciations between breast cancer and PCE exposure.
Methods
Study Population
The population-based case-control study was designed to
evaluate the association between breast cancer and tetra-
chloroethylene (PCE) exposure from public drinking
water [5]. During the period 1987–1993, the Massachu-
setts Cancer Registry recorded 672 incident cases of
female breast cancer among permanent residents of the
Massachusetts towns Barnstable, Bourne, Brewster,
Chatham, Falmouth, Mashpee, Provincetown, and Sand-
wich, where pipes with PCE-containing vinyl liners had
been installed.
Female controls were chosen to represent the underlying
population that gave rise to the cases. Selection criteria
required controls to be permanent residents of the same
towns during 1987–1993. Controls were frequency
matched to cases on age and vital status. Because many of
the cases were elderly or deceased, three different sources
of controls were used: (1) random digit dialing identified
living controls less than 65 years of age; (2) Centers for
Medicare and Medicaid Services, formerly the Health Care
Financing Administration, identified the living controls
65 years of age or older; and (3) death certificates identi-
fied controls who had died from 1987 onward. The result-
ing 616 controls provide an estimate of the exposure
distribution in the underlying population.
Subjects or their next-of-kin completed extensive inter-
views, which provided information on demographics
(e.g., age, sex, marital status, education), a 40-year resi-
dential history, and potential confounders (e.g., age, fam-
ily history of breast cancer, age of first live or still birth,
oral contraceptive use). Next-of-kin served as proxies for
cases and controls who were deceased or too ill to partici-
pate in the interview. "Index years" were randomly
assigned to controls to achieve a distribution similar to
that of cases' diagnosis years and only exposures before
the diagnosis year (for cases) and index year (for controls)
were counted. The analysis considered a range of latent
periods: 0, 5, 7, 9, 11, 13, 15, 17, and 19 years. For a
detailed description of the methods, see Aschengrau et al.
[5].
Dose Model
If individual behavior in water use is an important ele-
ment in a person's exposure, using the relative delivered
dose (RDD) could bias the results. The RDD quantifies the
amount of PCE in the drinking water, but does not con-
sider exposure from inhalation, dermal absorption, and
ingestion. PCE is a volatile organic compound and daily
indoor inhalation exposure to contaminated water from
showering can be up to six times greater than exposure
from ingestion [10]. To further quantify dose and reduce
exposure misclassification, a number of personal factors
(e.g., bottled water consumption, duration and frequency
of showers and baths) were considered.
Non-proxy cases and controls were interviewed about
many of these factors: the number of glasses of tap water
consumed per day, including drinks made with tap water,
such as coffee or lemonade; the use of bottled water; and
the temperature, frequency, and duration of showers and
baths. Information on a subject's physical characteristics,
such as height and usual weight, was also obtained.Environmental Health: A Global Access Science Source 2005, 4:3 http://www.ehjournal.net/content/4/1/3
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Certain model parameters not provided by the question-
naire were obtained from the current scientific literature
(e.g., inhalation rate, water flow rate, air exchange rate).
We used this information to construct a personal deliv-
ered dose (PDD) model that considered three exposure
routes: inhalation, dermal absorption, and ingestion. The
RDD value was converted into an annual concentration
and used as the initial water concentration for the PDD
model (mg/L). The amount of PCE contributed by inhala-
tion is a function of the temperature, frequency and dura-
tion of baths and showers, and the concentration of PCE
in the bathtub/shower stall air. To determine the amount
of PCE that volatilized from the water, the two-resistance
theory was applied to temperature dependent physical
and chemical properties of PCE [11]. The dermal absorp-
tion component of the model estimated each subject's
surface area (from her height and weight) and determined
the amount of PCE absorbed during baths and showers
using Fick's first law [12]. The amount of PCE that a sub-
ject ingested was dependent on the volume of tap water
consumed. By summing the total amount of PCE from the
three exposure routes over all exposed residences, we
arrived at a personal delivered dose (PDD) for each sub-
ject. A detailed description of the dose model is provided
in Additional file 1: Dose Model Appendix.
Data Analysis
Questions regarding tap water use and bathing habits
were not asked in proxy interviews so the PDD analysis
was restricted to non-proxy subjects (n = 885, Table 1). To
accurately compare results from the RDD and PDD anal-
yses, we first recalculated associations using the original
RDD exposure measure for only the non-proxy subjects.
Women with cumulative RDD exposures were compared
with never-exposed women. Never-exposed women did
not live downstream of vinyl-lined pipes.
We defined a series of four exposure levels based on the
exposure distribution of exposed controls. The lowest
exposure level included all exposed subjects with RDD
values less than or equal to the 50th  percentile. The
remaining exposure levels were nested and included all
RDD values greater than the 50th percentile, greater than
the 75th percentile, and greater than the 90th percentile.
Therefore, a subject exposed at > 90th percentile was also
considered exposed at > 75th and >50th percentiles. We
chose to nest exposure categories because there were too
few subjects for mutually exclusive categories. There are
no previous studies comparing nested exposure categories
to mutually exclusive exposure categories.
Exposure groups were further categorized for latent peri-
ods that ranged from 0 to 19 years. Each exposure level
was treated as a binary variable in separate multiple logis-
tic regression models. Odds ratios (ORs) were calculated
for each exposure level relative to never-exposed cases (n
= 360) and controls (n = 336). The adjusted analysis con-
trolled for a group of core confounders: age at diagnosis or
index year, family history of breast cancer, personal his-
tory of breast cancer (before current diagnosis or index
year), age at first live birth or stillbirth, and occupational
exposure to PCE. These factors were chosen as confound-
ers a priori based on the current scientific literature. Addi-
tional potential confounders were added to the logistic
regression models along with the core confounders,
including history of benign breast disease; past use of
diethylstilbestrol, oral contraceptives, and menopausal
hormones; cigarette smoking history; alcohol drinking
history; history of ionizing radiation treatment; quetlet
index (measure of obesity); race; marital status; religion;
education level; and physical activity level. None of these
additional variables changed the adjusted estimates by
more than 10%, and so the final models included only the
core confounders. Adjusted analyses were not performed
if there were fewer than three exposed cases and three
exposed controls in an exposure level [5]. We calculated
Table 1: Number of subjects by proxy/non-proxy, PCE-exposed/unexposed, and case/control status.
Non-Proxy Subjects Proxy Subjects Total Subjects
PCE-exposed 189 102 291
Cases 101 54 155
Controls 88 48 136
Unexposed 696 301 997
Cases 360 157 517
Controls 336 144 480
Total 885 403 1288
Cases 461 211 672
Controls 424 192 616Environmental Health: A Global Access Science Source 2005, 4:3 http://www.ehjournal.net/content/4/1/3
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95% confidence intervals (CIs) for the adjusted ORs using
maximum likelihood estimates of the standard errors
[13].
We then repeated the crude and adjusted analyses using
each subject's personal delivered dose (PDD) as an expo-
sure measure. The PDD distributions of the exposed con-
trols were used to define the same four exposure levels:
less than or equal to the 50th percentile, greater than the
50th percentile, greater than the 75th percentile, and greater
than the 90th percentile. The referent category remained
never exposed cases and controls.
We also conducted a goodness-of-fit analysis to compare
the RDD and PDD exposure measures and to determine
which model performed better [14]. We compared the
deviance of the models at different exposure levels and
latencies. Lastly, we performed a nonparametric rank test
to determine if the ranks of the subjects' PDD exposures




We were interested in comparing the results of the
Aschengrau et al. RDD analysis using all subjects to the
restricted analysis performed on only non-proxy subjects.
The distributions of core confounders were similar among
non-proxy and all subjects, except non-proxy subjects
were younger than all subjects (Table 2). The number of
exposed subjects was reduced by 35% when proxies were
removed (from 291 to 189) when no latency was consid-
ered. The number of unexposed subjects used as a com-
mon reference group for all analyses was reduced by 30%
(from 997 to 696). The median, 75th percentile, and 90th
percentile RDD values for the non-proxy exposed controls
were similar to the values for the exposed controls among
all subjects (Table 2). We compared analyses for ever vs.
never PCE-exposed and found that the odds ratios were
similar for the non-proxy subjects and all subjects (Table
3) [5].
PDD analysis
The distribution of cumulative RDD and PDD values
ranged by five orders of magnitude, equivalent to a range
from micrograms to hundreds of milligrams. Of the 189
exposed subjects in the no latency analysis, the personal
delivered dose model changed the exposure categories of
39 subjects. However, the result from a non-parametric
signed rank test indicates that the subjects' RDD ranks and
PDDs rank are not significantly different (p = 0.81).
In general, odds ratios from the PDD analysis were
slightly higher than the RDD analysis for exposure levels
above the 50th and 75th percentiles at shorter latency peri-
ods (see Additional file 2: Table 4). At longer latencies, the
ORs for the lowest and highest exposure groups in the
PDD analysis were slightly higher than the RDD analysis,









Age at diagnosis or index years
1–49 years 19.7 (91) 20.6 (87) 16.5 (111) 16.7 (103)
50–59 years 13.7 (63) 17.0 (72) 12.2 (82) 13.6 (84)
60–69 years 33.0 (152) 31.1 (132) 31.5 (211) 29.9 (184)
70–79 years 28.8 (133) 25.2 (107) 28.4 (191) 26.0 (160)
80+ years 4.8 (22) 6.1 (26) 11.4 (77) 13.8 (85)
Age at first birth or stillbirth
< 30 years 60.6 (279) 65.7 (278) 61.0 (410) 66.8 (411)
30+ years 13.8 (64) 12.4 (53) 14.5 (97) 12.8 (79)
Nulliparous 25.6 (118) 21.9 (93) 24.5 (165) 20.4 (126)
Prior breast cancer 5.6 (26) 3.3 (14) 5.4 (36) 4.8 (30)
Family history of breast cancer 24.3 (112) 15.8 (67) 25.6 (172) 15.5 (95)
Occupational exposure to PCE 16.3 (75) 16.0 (68) 15.5 (104) 14.8 (91)
RDD Exposure (for no latency)
Minimum --- 0.001 --- 0.001
Maximum --- 206.9 --- 243.8
Median --- 2.9 --- 2.5
75th percentile --- 11.9 --- 12.1
90th percentile --- 31.0 --- 29.2Environmental Health: A Global Access Science Source 2005, 4:3 http://www.ehjournal.net/content/4/1/3
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but small numbers of exposed subjects limited the
adjusted analyses. The odds ratios for breast cancer
increased with increased latency and higher exposure cat-
egories, although the odds ratios were not statistically sig-
nificant. The confidence intervals were generally the same
width for both the RDD and PDD analyses; they included
the null value in both analyses, and grew wider as the
exposure level and latency increased. Overall, the results
from the PDD analysis did not differ greatly from the
RDD analysis and any differences were well within the
variation present in the RDD data, which formed the
"input" to the PDD analysis.
The best fitting model is often but not always the one that
produces the higher odds ratio [14]. The deviance meas-
ure of goodness-of-fit was smaller for the PDD than the
RDD model at shorter latencies and lower exposure levels
and larger at longer latencies and higher exposure levels.
However, the close agreement between the goodness-of-
fit measures suggests that there is little difference between
the two models (see Additional file 3: Table 5). Further
evidence of this is provided by the results of the nonpara-
metric rank test, which indicated the two exposure rank-
ings were not statistically different.
Discussion
The dose model was constructed to reduce nondifferential
exposure misclassification due to variations in personal
behavior. In the RDD analysis, exposure was based solely
on subjects' RDD values and did not take into considera-
tion factors such as bathing habits and bottled water con-
sumption. Nondifferential exposure misclassification
should bias results towards the null when the exposure is
dichotomous. Based on this reasoning, we expected the
moderate elevations in risk observed in the RDD analysis
by Aschengrau et al. [5] to increase further in the current
PDD analysis. The results show that, in general, this was
not the case.
Overall, the risks calculated from the PDD analysis dif-
fered only slightly from the RDD analysis, if at all. The fact
that the PDD model did not increase the odds ratios may
be due to a number of reasons. A possible explanation is
that no association exists between exposure to PCE and
breast cancer, but there is a fairly large body of literature
now that supports a carcinogenic effect for PCE in
humans. The biologic rationale for a breast cancer effect
stems from a hypothesis described by Labreche and Gold-
berg that organic solvents such as PCE may act either
directly as genotoxic agents or indirectly through their
metabolites to increase the risk of breast cancer [15].
More likely, the impact of variations in personal habits
was small in comparison to variations in characteristics of
the drinking water distribution system, or the question-
naire information did not accurately account for individ-
ual variations. Errors in estimating the RDD values used in
the dose model may explain why the model made little
difference in determining risk. Improper assumptions or
incorrect input variables in the Webler-Brown model led
Table 3: Tetrachloroethylene exposure history of breast cancer subjects, adjusteda odds ratios, and 95% confidence intervals.
Latency period, years Exposed Cases Exposed Controls Adjusted ORs (95 % CI)
0 Non-proxy Subjects 101 88 1.1 (0.8–1.5)
All Subjects 155 136 1.1 (0.8–1.4)
5 Non-proxy Subjects 87 69 1.2 (0.9–1.8)
All Subjects 129 107 1.2 (0.9–1.6)
7 Non-proxy Subjects 71 61 1.1 (0.8–1.6)
All Subjects 111 96 1.1 (0.8–1.5)
9 Non-proxy Subjects 63 57 1.1 (0.7–1.6)
All Subjects 97 85 1.1 (0.8–1.5)
11 Non-proxy Subjects 49 43 1.1 (0.6–1.7)
All Subjects 79 65 1.2 (0.8–1.7)
13 Non-proxy Subjects 43 32 1.3 (0.7–2.1)
All Subjects 61 45 1.3 (0.9–2.0)
15 Non-proxy Subjects 30 21 1.4 (0.7–2.6)
All Subjects 44 31 1.4 (0.9–2.3)
17 Non-proxy Subjects 15 15 1.0 (0.4–2.2)
All Subjects 21 21 1.0 (0.6–2.0)
19 Non-proxy Subjects 6 6 1.1 (0.3–3.5)
All Subjects 9 9 1.1 (0.4–2.9)
a The OR was calculated relative to never-exposed cases (n = 360 for Non-Proxy, n = 517 for ALL) and controls (n = 336 for Non-Proxy, n = 
480 for All). Controlled for age at diagnosis or index year, family history of breast cancer, personal history of breast cancer (before current 
diagnosis or index year), age at first live-birth or still birth, occupational exposure to PCE, and vital status at interview (for All analysis only).Environmental Health: A Global Access Science Source 2005, 4:3 http://www.ehjournal.net/content/4/1/3
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to errors in the RDD values [5]. The resulting exposure
misclassification would not be corrected using the dose
model. As a result, the dose model would still be biased.
Furthermore, both RDD and PDD are measures of cumu-
lative exposure, where exposure was summed over a sub-
ject's residences on Cape Cod. One subject may have been
exposed at a high intensity for two or more short resi-
dency durations while another subject with the same
exposure value may have been exposed at a low intensity
for one long residency duration. The exposure pattern can
influence cancer risk if, for example, a threshold intensity
of PCE must be reached in order to cause breast cancer or
if breast cancer induction requires prolonged continuous
exposure [16].
Another limitation of the analysis was the restriction to
subjects with non-proxy interviews, which reduced the
sample size by 31%. When all subjects were included in
the RDD analysis, small to moderate increases were
observed among women whose exposure level was greater
than the 90th percentile [5]. When only non-proxy sub-
jects were included, we no longer observed moderate
increases. This difference may be due to the fact that the
maximum RDD value was higher for all subjects than for
non-proxies. Therefore, the use of only non-proxy subjects
may not accurately reflect population risk. Imputing val-
ues for proxy subjects is a possible option for future
analyses.
Faulty recall in the behavioral data is another possible rea-
son why the PDD model did not strengthen the associa-
tion between breast cancer and PCE. Subjects were asked
to remember details about bathing habits and drinking
water that occurred up to forty years before the interview.
As a result, the exposure data obtained at interview may
not be accurate.
The inputs that most heavily influenced the PDD model
were initial water concentration and duration of exposure.
These variables were also included in the RDD model. In
this study population, personal factors like bath and
shower temperature, bathing frequencies and durations,
and water consumption did not differ greatly among sub-
jects. Therefore, including these characteristics in the PDD
model did not significantly improve the exposure meas-
ure or change which subjects were considered exposed
and to what level they were exposed.
Conclusion
In an attempt to characterize PCE exposure more pre-
cisely, we constructed a dose model that considered expo-
sure from inhalation, ingestion, and dermal absorption.
The model incorporated personal information on tap
water use and bathing habits obtained from study inter-
views. The dose values calculated by the model were sub-
sequently used to measure the strength of the association
between PCE exposure and the risk of breast cancer.
Although our results from the PDD analysis did not differ
greatly from the RDD analysis, it remains important to
assess exposure as accurately as practical in an epidemio-
logical investigation. Many factors such as tap water use
and bathing habits could be considered when determin-
ing exposure to volatile chemicals in domestic water sup-
plies, but our analysis suggests that the use of such
ancillary data does not always result in an improvement
in exposure accuracy if the ancillary data are inaccurate or
if they have little effect on an individual's exposure level.
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This document describes the dose model in more detail.




This document provides a table of adjusted odds ratios for breast cancer by 
tetrachloroethylene exposure levels in RDD and PDD analyses.




This document provides a table of deviance measures for logistic regression 
models by tetrachloroethylene exposure levels in RDD and PDD analyses.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
069X-4-3-S3.doc]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Environmental Health: A Global Access Science Source 2005, 4:3 http://www.ehjournal.net/content/4/1/3
Page 7 of 7
(page number not for citation purposes)
Acknowledgements
This work has been supported by grant 2P42 ES07381 from the National 
Institute of Environmental Health Sciences (NIEHS) with funds from the 
U.S. Environmental Protection Agency (EPA). Its contents are solely the 
author's responsibility and do not necessarily represent the official views of 
the NIEHS or the EPA.
References
1. Aschengrau A, Ozonoff D, Paulu C, Coogan P, Vezina R, Heeren T,
Zhang Y: Cancer risk and tetrachloroethylene-contaminated
drinking water in Massachusetts.  Arch Environ Health 1993,
48:284-292.
2. Aschengrau A, Ozonoff D, Coogan P, Vezina R, Heeren T, Zhang Y:
Cancer risk and residential proximity to cranberry cultiva-
tion in Massachusetts. Am J Public Health 1996, 86:1289-1296.
3. Aschengrau A, Paulu C, Ozonoff D: Tetrachloroethylene-con-
taminated drinking water and the risk of breast cancer. Envi-
ron Health Perspect 1998, 106:947-953.
4. Ozonoff D, Aschengrau A, Coogan P: Cancer in the vicinity of a
Department of Defense superfund site in Massachusetts. Tox-
icol Ind Health 1994, 10:119-141.
5. Aschengrau A, Rogers S, Ozonoff D: Perchloroethylene-contam-
inated drinking water and the risk of breast cancer: Addi-
tional results from Cape Cod, Massachusetts, USA. Environ
Health Perspect 2003, 111:167-173.
6. Paulu C, Aschengrau A, Ozonoff D: Tetrachloroethylene-con-
taminated drinking water and the risk of colon-rectum, lung,
and other cancers. Environ Health Perspect 1999, 107:265-271.
7. Brody J, Aschengrau A, McKelvey W, Rudel R, Swartz C, Kennedy T:
Breast cancer risk and historical exposure to pesticides from
wide-area applications assessed with GIS.  Environ Health
Perspect 2004, 112:889-897.
8. Demond A: A source of tetrachloroethylene in the drinking
water of New England: an evaluation of the toxicity of tetra-
chloroethylene and the prediction of its leaching rates from
vinyl-lined asbestos-cement pipe. In MS thesis MIT, Department
of Civil and Environmental Engineering; 1982. 
9. Webler T, Brown H: Exposure to tetrachloroethylene via con-
taminated drinking water pipes in Massachusetts: a predic-
tive model. Arch Environ Health 1993, 48:293-297.
10. McKone T: Human exposure to volatile organic compounds in
household tap water: the indoor inhalation pathway. Environ
Sci Technol 1987, 21:1194-1201.
11. Little J: Applying the two-resistance theory to contaminant
volatilization in showers. Environ Sci Technol 1992, 26:1341-1349.
12. U.S. EPA. Dermal exposure assessment – principles and
applications. Report 600-8-91-011B  [http://www.epa.gov/
NCEA/pdfs/dermalexp.pdf]
13. Rosner B: Fundamentals of Biostatistics 5th edition. Pacific Grove,
CA:Duxbury; 2000. 
14. Salvan A, Stayne L, Steenland K, Smith R: Selecting an exposure
lag period. Epidemiology 1995, 6:387-390.
15. Labreche F, Goldberg M: Exposure to organic solvents and
breast cancer in women: a hypothesis.  Am J Ind Med 1997,
32:1-14.
16. Checkoway H, Pearce N, Crawford-Brown D: Research Methods in
Occupational Epidemiology New York: Oxford University Press; 1989. 
17. Little J: Comment on "Human exposure to volatile organic
compounds in household tap water: the inhalation pathway".
Environ Sci Technol 1992, 26:836-8.
18. Cleek R, Bunge A: A new method for estimating dermal
absorption from chemical exposure. 1. General Approach.
Pharm Res 1993, 10:497-506.
19. Potts R, Guy R: Predicting skin permeability. Pharm Res 1992,
9:663-669.
20. Giardino N, Andelman J: Characterization of the emissions of
trichloroethylene, chloroform, and 1,2-dibromo-3-chloro-
propane in a full-size experimental shower. J Expo Anal Environ
Epidemiol 1996, 6:413-423.
21. Vieira V: Methods in exposure assessment and spatial epide-
miology. In ScD thesis Boston University School of Public Health,
Department of Environmental Health; 2003. 